Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives
Publié dansEuropean journal of nuclear medicine and molecular imaging, vol. 48, no. 7, p. 2157-2168
Date de publication2021-07
Date de mise en ligne2021-02-17
Résumé
Mots-clés
- Alzheimer’s disease
- Amyloid-PET
- Clinical utility
- Diagnostic biomarkers
- Outcome
- Systematic review
- Alzheimer Disease
- Amyloid
- Amyloidosis
- Humans
- Positron-Emission Tomography
- Quality of Life
Financement
- FNS - [320030_169876, 320030_185028]
- FNS - IZSEZO [188355]
Citation (format ISO)
COTTA RAMUSINO, Matteo et al. Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives. In: European journal of nuclear medicine and molecular imaging, 2021, vol. 48, n° 7, p. 2157–2168. doi: 10.1007/s00259-020-05187-x
Fichiers principaux (1)
Article (Published version)
Fichiers secondaires (1)
Identifiants
- PID : unige:160858
- DOI : 10.1007/s00259-020-05187-x
- PMID : 33594474
- PMCID : PMC8175294
ISSN du journal1619-7070